Gufic BioSciences
add_icon

Gufic BioSciences

289.30
-0.35
(-0.12%)
Market Cap
2,901.17 Cr
PE Ratio
58.20
Volume
52,293.00
Day High - Low
300.05 - 285.30
52W High-Low
407.85 - 268.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
2,901.17 Cr
EPS
6.95
PE Ratio
58.20
PB Ratio
4.61
Book Value
62.94
EBITDA
139.70
Dividend Yield
0.03 %
Industry
Healthcare
Return on Equity
11.59
Debt to Equity
0.59
Forecast For
Actual

Company News

View All News
Caret
neutral
Gufic Biosciences Limited has scheduled its Q3FY26 earnings conference call for February 16, 2026 at 4:30 PM IST to discuss financial performance and business prospects with investors and analysts.
negative
Gufic Biosciences receives income tax demand of ₹4.33 crores for AY 2024-25 due to expenditure disallowance. Company plans to file appeal with Commissioner of Income Tax.
negative
Gufic Biosciences received GST penalty order totaling ₹15,64,052 for FY2018-19 to FY2022-23 related to excess Input Tax Credit claims and short payment of tax liability. Company plans to appeal.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,825.90
#1 4,38,094.57
39.72
#1 54,729.00
9.71
#1 10,980
16.07
70.51
6,352.50
1,68,638.92
68.23
9,712.00
18.67
2,191
-1.02
53.61
4,431.20
1,49,971.94
65.93
11,539.40
6.99
1,911
26.24
67.89
1,325.50
1,10,630.25
19.86
33,741.20
16.73
5,725
-15.28
61.94
1,329.50
1,07,393.26
23.75
28,409.50
7.12
5,291
-57.18
44.79
2,344.60
1,07,101.05
22.91
22,909.50
13.74
3,306
#1 37.44
66.27
921.75
92,749.62
#1 18.48
23,511.00
18.55
4,615
-0.32
54.61
2,243.80
92,625.20
51.23
12,744.20
#1 20.90
2,007
7.65
59.70
1,304.80
75,783.00
21.43
32,345.60
9.43
3,484
7.59
69.59
5,544.50
66,292.81
27.73
13,458.30
3.70
2,216
1.90
48.24
Growth Rate
Revenue Growth
1.81 %
Net Income Growth
-19.16 %
Cash Flow Change
1,743.03 %
ROE
-28.32 %
ROCE
-16.55 %
EBITDA Margin (Avg.)
-7.27 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
196
215
202
196
204
204
210
205
225
239
232
Expenses
159
176
165
161
167
166
174
179
190
199
198
EBITDA
36
40
37
35
37
39
36
27
34
40
34
Operating Profit %
18 %
18 %
18 %
18 %
18 %
19 %
16 %
13 %
15 %
16 %
14 %
Depreciation
4
4
4
4
4
4
5
8
8
8
8
Interest
4
5
3
4
5
5
5
8
9
10
8
Profit Before Tax
28
31
30
27
28
29
26
11
17
23
18
Tax
7
8
7
7
7
8
7
3
4
6
5
Net Profit
21
23
22
20
21
22
19
8
13
17
12
EPS in ₹
2.13
2.39
2.23
2.00
2.08
2.17
1.93
0.77
1.30
1.68
1.24

Balance Sheet

Balance Sheet
2024
2025
Total Assets
1,093
1,169
Fixed Assets
159
506
Current Assets
601
625
Capital Work in Progress
307
22
Investments
2
2
Other Assets
625
640
Total Equity & Liabilities
1,093
1,169
Current Liabilities
372
388
Non Current Liabilities
188
181
Total Equity
533
601
Reserve & Surplus
523
591
Share Capital
10
10

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
-28
15
Investing Activities
-102
-71
Operating Activities
-8
123
Financing Activities
82
-37

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
65.75 %
65.13 %
75.48 %
75.48 %
75.48 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
72.51 %
72.51 %
72.51 %
72.51 %
72.51 %
72.51 %
72.51 %
72.51 %
72.50 %
72.50 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.72 %
0.00 %
0.12 %
0.23 %
0.24 %
0.30 %
0.31 %
0.32 %
0.34 %
0.44 %
DIIs
8.25 %
3.24 %
2.13 %
1.19 %
1.03 %
1.03 %
1.16 %
1.16 %
1.16 %
1.16 %
1.50 %
1.58 %
1.60 %
2.20 %
2.39 %
2.51 %
2.98 %
3.39 %
3.38 %
3.65 %
3.74 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
21.92 %
27.67 %
17.00 %
17.40 %
17.65 %
17.84 %
18.29 %
18.24 %
17.83 %
17.84 %
17.16 %
16.66 %
16.85 %
16.72 %
16.36 %
16.01 %
15.44 %
15.15 %
15.10 %
14.45 %
14.13 %
Others
4.08 %
3.95 %
5.39 %
5.94 %
5.84 %
6.13 %
5.55 %
5.60 %
6.01 %
6.00 %
6.34 %
8.53 %
9.04 %
8.45 %
8.52 %
8.73 %
8.76 %
8.64 %
8.70 %
9.06 %
9.19 %
No of Share Holders
19,639
45,602
35,135
34,580
38,144
40,120
41,376
40,562
38,902
38,624
36,557
36,524
34,424
34,695
32,250
32,825
33,299
31,844
31,876
31,420
30,362

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.05 0.05 0.05 0.05 0.1 0.1 0.1 0.1 0.1 0.00
Dividend Yield (%) 0.05 0.07 0.1 0.04 0.04 0.05 0.04 0.03 0.03 0.00

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 24, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 16, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 13, 2026
Announcement under Regulation 30 (LODR)-AcquisitionFeb 13, 2026
Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025Feb 13, 2026
Board Meeting Outcome for For Meeting Held On Friday February 13 2026Feb 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2026
Board Meeting Intimation for Consideration And Approval Of Inter Alia Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025Feb 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Closure of Trading WindowDec 30, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 27, 2025
Intimation Of Environmental Social And Governance (ESG) RatingDec 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 21, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 14, 2025
Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025Nov 14, 2025
Board Meeting Outcome for Meeting Held On Friday November 14 2025Nov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Credit RatingNov 10, 2025
Board Meeting Intimation for Consideration And Approval Of Inter Alia Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30 2025Nov 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 18, 2025
Promotion And Re-Designation Of Senior Management Personnel - Mr. Shekhar Tarbir Aley As President - Critical Care Sbus Nepal & InstitutionSep 16, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2025
Business Responsibility and Sustainability Reporting (BRSR)Sep 05, 2025
Reg. 34 (1) Annual Report.Sep 05, 2025
Intimation Of Record Date For Final Dividend & 41St Annual General MeetingSep 05, 2025
Shareholders Meeting - 41St Annual General Meeting Of The Company Scheduled To Be Held On Monday September 29 2025Sep 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionAug 26, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 13, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 13, 2025
Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025Aug 13, 2025

Technical Indicators

RSI(14)
Neutral
47.64
ATR(14)
Volatile
11.72
STOCH(9,6)
Neutral
41.95
STOCH RSI(14)
Neutral
79.63
MACD(12,26)
Bullish
0.84
ADX(14)
Strong Trend
31.20
UO(9)
Bearish
58.59
ROC(12)
Uptrend And Accelerating
1.01
WillR(14)
Neutral
-30.16